TcrossGlobal

FIRM-Guided Reablation for Atrial Fibrillation: The REDO-FIRM Trial

The REDO-FIRM trial showed that focal impulse and rotor modulation (FIRM) ablation did not provide additional benefit compared to standard ablation in patients with recurrent atrial fibrillation after ablation for atrial fibrillation but was safe. Dr. Stefan G Spitzer, Brandenburg University of Technology Cottbus-Senftenberg, Germany, and colleagues reported in the January issue of EP Europace.

The REDO-FIRM trial enrolled patients from multiple centers who had recurrent persistent or paroxysm...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.

Recommendations

Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry

Others

$The effectiveness of the current lipid-lowering therapy for refractory dyslipidaemia in patients with coronary artery disease: the price of ‘the lower, the better’- results of a survey by Japanese cardiologists$